000 | 01151 a2200313 4500 | ||
---|---|---|---|
005 | 20250514025524.0 | ||
264 | 0 | _c20020408 | |
008 | 200204s 0 0 eng d | ||
022 | _a1472-8222 | ||
024 | 7 |
_a10.1517/14728222.6.1.21 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKhasnobis, Shampa | |
245 | 0 | 0 |
_aEmerging therapeutic targets in tuberculosis: post-genomic era. _h[electronic resource] |
260 |
_bExpert opinion on therapeutic targets _cFeb 2002 |
||
300 |
_a21-40 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntitubercular Agents _xchemistry |
650 | 0 | 4 |
_aCell Wall _xchemistry |
650 | 0 | 4 | _aDrug Resistance, Microbial |
650 | 0 | 4 | _aGenome, Bacterial |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMycobacterium tuberculosis _xdrug effects |
650 | 0 | 4 |
_aTuberculosis _xdrug therapy |
700 | 1 | _aEscuyer, Vincent E | |
700 | 1 | _aChatterjee, Delphi | |
773 | 0 |
_tExpert opinion on therapeutic targets _gvol. 6 _gno. 1 _gp. 21-40 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1517/14728222.6.1.21 _zAvailable from publisher's website |
999 |
_c11807426 _d11807426 |